Advertisement

Der Internist pp 515-520 | Cite as

Heparininduzierte Thrombozytopenie und Thrombose

  • P. Langecker
  • H. Riess
  • E. Hiller
  • W. Wilmanns
Chapter

Zusammenfassung

Ein 24jähriger Offizier erleidet beim Sport eine Verletzung des linken Knies, die zu einer schmerzhaften Bewegungseinschränkung führt. Der junge Mann ist bis zu diesem Zeitpunkt nie ernsthaft krank gewesen und von überdurchschnittlicher körperlicher Leistungsfähigkeit.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Salem HH, van der Weyden MB (1983) Heparin induced thrombocytopenia: variable platelet-rich plasma reactivity to heparin dependent platelet aggregating factor. Pathology 15:279–9CrossRefGoogle Scholar
  2. 2.
    King DJ, Keiton JD (1984) Heparin-as-sociated thrombozytopenia. Ann Intern Med 100:535–40PubMedCrossRefGoogle Scholar
  3. 3.
    Gollub S, Ulin AN (1962) Heparin induced thrombocytopenia in man. J Lab Clin Med 59:430–5PubMedGoogle Scholar
  4. 4.
    Nelson JC, Lerner RE, Goldstein R, Cagin N A (1978) Heparin-induced thrombocytopenia. Arch Intern Med 138:548–52PubMedCrossRefGoogle Scholar
  5. 5.
    Towne JB, Bernhard VM, Hussey C, Garancis JC (1979) White clot syndrome: peripheral vascular complications of heparin therapy. Arch Surg 114:372–7PubMedCrossRefGoogle Scholar
  6. 6.
    Weismann RE, Tobin RW (1958) Arterial embolism occurring during systemic heparin therapy. Arch Surg 76:219–27CrossRefGoogle Scholar
  7. 7.
    Chong BH, Pitney WR, Castaldi PA (1982) Heparin induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet 11:1246–9CrossRefGoogle Scholar
  8. 8.
    Ehrlich J, Stivala SS (1983) Chemistry and pharmacology of heparin. J Pharm Sci 62:527–44Google Scholar
  9. 9.
    Bounameaux H, Marbet GA, Lämmle B, Eichlisberger R, Duckert F (1980) Monitoring of heparin treatment. Comparison of thrombin time, activated partial thromboplastin time and plasma heparin concentration and analysis of the behaviour of antithrombin III. Am J Clin Pathol 74:68–73PubMedGoogle Scholar
  10. 10.
    Thunberg L, Bäckström G, Grundberg H, Riesenfeld J, Lindahl U (1980) The molecular size of the antithrombin binding sequence in heparin. FEBS Lett 117:203–6PubMedCrossRefGoogle Scholar
  11. 11.
    Bell WR, Royall RM (1980) Heparin-associated thrombozytopenia: a comparison of three heparin preparations. N Engl J Med 303:902–7PubMedCrossRefGoogle Scholar
  12. 12.
    Fiessinger JN, Aiach M, Roncato C, Gaux JC (1984) Critical ischemia during heparin-induced thrombocytopenia. Treatment with intraarterial streptokinase. Thromb Res 33:235–8PubMedCrossRefGoogle Scholar
  13. 13.
    Roussi J, Houbouyan L, Rosenthal D, Toulemonde F, Goguel A (1983) Succes du traitement par une heparine de bas poids moleculaire dans un ca d’embolie pulmonaire compliquant une thrombo-penie induite par L’heparine. Nouv Rev Fr Hematol 25:273–4PubMedGoogle Scholar
  14. 14.
    Klein HC, Bell WR (1974) Disseminated intravascular coagulation during heparin therapy. Ann Intern Med 80:477–81PubMedCrossRefGoogle Scholar
  15. 15.
    Riess H, Hiller E (1984) Heparin and Thrombozytopenia. Ann Intern Med 12:875–6CrossRefGoogle Scholar
  16. 16.
    Fratantoni JC, Pollet R, Gralwick HR (1975) Heparin-induced thrombocytopenia: confirmation of diagnosis by in vitro methods. Blood 45:395–401PubMedGoogle Scholar
  17. 17.
    Pfueller SL, David R (1986) Different platelet specifities of heparin-dependent platelet aggregating factors in heparin-associated immune thrombocyopenia. Br J Haematol 64:149–59PubMedCrossRefGoogle Scholar
  18. 18.
    Green D, Harris K, Reynolds N, Roberts M, Patterson R (1978) Heparin immune thrombocytopenia: evidence for a heparin-platelet complex as the antigenic determinant. J Lab Clin Med 91:167–75PubMedGoogle Scholar
  19. 19.
    Gresele P, Deckmyn H, Huybrechts E, Vermylen J (1984) Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibitors by increasing the formation of prostaglandin D2. Biochem Pharmacol 33:2084–8CrossRefGoogle Scholar
  20. 20.
    Tangen O, Berman H J (1972) Gel filtration in blood platelets: a methodical report. In: Mannucci PM, Gorini S (eds) Platelet function and thrombosis. A review of methods. Adv Exp Med Biol 34:235–43CrossRefGoogle Scholar
  21. 21.
    Cines DB, Tomaski A, Tannenbaum S (1987) Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med 316:581–8PubMedCrossRefGoogle Scholar
  22. 22.
    Blockmans D, Bounameaux J, Vermylen J, Verstraete M (1986) Heparin-induced thrombocytopenia. Platelet aggregation studies in the presence of heparin fractions or semi-synthetic analogues of various molecular weights and anticoagulant activities. Thromb Haemost 55:90–93PubMedGoogle Scholar
  23. 23.
    Roussi JH, Houbouyan LL, Goguel AF (1984) Use of low-moleccular-weight heparin in heparin-induced thrombocytopenia with thrombotic complications. Lancet 1:1183PubMedCrossRefGoogle Scholar
  24. 24.
    Gallus A, Jackaman J, Tillett J, Mills W, Wacherley A (1986) Safety and efficacy of warfarin started early after sub-massivse venous thrombosis of pulmonary embolism. Lancet II: 1293–6CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • P. Langecker
    • 1
    • 2
    • 3
  • H. Riess
    • 1
  • E. Hiller
    • 1
  • W. Wilmanns
    • 1
    • 2
  1. 1.Institut für klinische Hämatologie der GSFMünchenDeutschland
  2. 2.Medizinische Klinik III, Klinikum GroßhadernLMUMünchenDeutschland
  3. 3.Medizinische Klinik III, Klinikum GroßhadernUniversität MünchenMünchen 70Deutschland

Personalised recommendations